Safety and Efficacy of Anti-PD-1/PD-L1 Inhibitors Compared With Docetaxel for NSCLC: A Systematic Review and Meta-Analysis

Objective: To evaluate the efficacy and safety of anti-PD-1/PD-L1 Inhibitors versus docetaxel for non-small cell lung cancer by meta-analysis. Methods: Randomized controlled trials (RCTs) about anti-PD-1/PD-L1 Inhibitors versus docetaxel on the treatment of NSCLC were searched in CNKI, WF, VIP, PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Long, Jin, Gang, Yao, Keying, Yang, Yi, Chang, Ruitong, Wang, Wenhao, Liu, Jiawei, Zhu, Zijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397376/
https://www.ncbi.nlm.nih.gov/pubmed/34456725
http://dx.doi.org/10.3389/fphar.2021.699892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397376/
https://www.ncbi.nlm.nih.gov/pubmed/34456725
http://dx.doi.org/10.3389/fphar.2021.699892

Ejemplares similares